 |
|
Statin Use and Survival Outcomes in Elderly Patients With Heart Failure
Joel G. Ray, MD, MSc;
Yanyan Gong, MSc;
Kathy Sykora, MSc;
Jack V. Tu, MD, PhD
Arch Intern Med. 2005;165:62-67.
Background Coronary artery disease is a leading cause of heart failure. Statins are efficacious drugs for the primary and secondary prevention of coronary heart disease, but their value in persons with heart failure remains unknown.
Methods We performed a population-based retrospective cohort study involving the entire province of Ontario, Canada, restricting participants to those aged 66 to 85 years who were free of cancer and who survived at least 90 days following hospitalization for newly diagnosed heart failure. The primary study outcome was the risk of death from all causes, nonfatal acute myocardial infarction, or nonfatal stroke among persons newly dispensed statins (n = 1146) relative to those who were not (n = 27 682).
Results The mean age of all participants was 76.5 years, and half were women. During the 7-year study period, death, acute myocardial infarction, or stroke occurred in 217 statin recipients (13.6 per 100 person-years) vs 12 299 nonrecipients (21.8 per 100 person-years; adjusted hazard ratio [HR], 0.72; 95% confidence interval [CI], 0.63-0.83). Most of the benefit from statins was related to a reduction in all-cause mortality (adjusted HR, 0.67; 95% CI, 0.57-0.78). No significant reduction was seen for subsequent myocardial infarction (adjusted HR, 0.81; 95% CI, 0.63-1.03) or stroke (adjusted HR, 0.81; 95% CI, 0.53-1.25).
Conclusions Statin use is associated with a lower risk of death among seniors newly diagnosed as having congestive heart failure. While statin use has been previously shown to be efficacious in patients with coronary heart disease and stroke, we could not control for all prognostic risk factors in the present study, including left ventricular ejection fraction and serum lipid levels. Better evidence can direct clinicians about which patients with heart failure might benefit from these drugs.
Author Affiliations: Department of Medicine, St Michael’s Hospital, University of Toronto (Dr Ray); Programming and Biostatistics & Canadian Cardiovascular Outcome Research Team, Institute for Clinical Evaluative Sciences (Ms Gong); Canadian Cardiovascular Outcome Research Team, Institute for Clinical Evaluative Sciences (Ms Sykora); and Institute for Clinical Evaluative Science, Department of Medicine, Sunnybrook & Women’s College Health Sciences Centre, University of Toronto (Dr Tu), Toronto, Ontario.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Immeasurable Time Bias in Observational Studies of Drug Effects on Mortality
Suissa
Am J Epidemiol 2008;168:329-335.
ABSTRACT
| FULL TEXT
Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.
Ramasubbu et al.
J Am Coll Cardiol 2008;51:415-426.
ABSTRACT
| FULL TEXT
Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes
Gislason et al.
Circulation 2007;116:737-744.
ABSTRACT
| FULL TEXT
Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure
Tang et al.
J Am Coll Cardiol 2007;49:2364-2370.
ABSTRACT
| FULL TEXT
Lipid-Lowering Therapy and Outcomes in Heart Failure
Ray et al.
J CARDIOVASC PHARMACOL THER 2007;12:27-35.
ABSTRACT
Statin therapy and risks for death and hospitalization in chronic heart failure.
Go et al.
JAMA 2006;296:2105-2111.
ABSTRACT
| FULL TEXT
Heart failure: statins for all?
Leite-Moreira and Castro-Chaves
Heart 2006;92:1537-1538.
FULL TEXT
Intensive Statin Therapy and the Risk of Hospitalization for Heart Failure After an Acute Coronary Syndrome in the PROVE IT-TIMI 22 Study
Scirica et al.
J Am Coll Cardiol 2006;47:2326-2331.
ABSTRACT
| FULL TEXT
Statins and Mortality Among Elderly Patients Hospitalized With Heart Failure
Foody et al.
Circulation 2006;113:1086-1092.
ABSTRACT
| FULL TEXT
Atorvastatin Improves Left Ventricular Systolic Function and Serum Markers of Inflammation in Nonischemic Heart Failure
Sola et al.
J Am Coll Cardiol 2006;47:332-337.
ABSTRACT
| FULL TEXT
The Year in Heart Failure
Tang and Francis
J Am Coll Cardiol 2005;46:2125-2133.
FULL TEXT
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics
Kjekshus et al.
Eur J Heart Fail 2005;7:1059-1069.
ABSTRACT
| FULL TEXT
Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure: A Preliminary Report
Fukuta et al.
Circulation 2005;112:357-363.
ABSTRACT
| FULL TEXT
Statin Therapy in Congestive Heart Failure
Keller and Lemberg
Am J Crit Care 2005;14:338-340.
FULL TEXT
|
